Skip to content
2000
Volume 14, Issue 17
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Molecular hybridization is a new concept in drug design and development based on the combination of pharmacophoric moieties of different bioactive substances to produce a new hybrid compound with improved affinity and efficacy, when compared to the parent drugs. Additionally, this strategy can result in compounds presenting modified selectivity profile, different and/or dual modes of action and reduced undesired side effects. So, in this paper, we described several examples of different strategies for drug design, discovery and pharmacomodulation focused on new innovative hybrid compounds presenting analgesic, anti-inflammatory, platelet anti-aggregating, anti-infectious, anticancer, cardio- and neuroactive properties.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/092986707781058805
2007-07-01
2025-05-03
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/092986707781058805
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test